Search

8 result(s)

Elysia has won Deloitte’s 2019 Technology Fast 50 award
The Technology Fast 50 competition is an annual selection of the 50 fastest growing and innovative technology companies headquartered in Belgium. Public or private companies who develop a technology related product or service and who have experienced substantial revenue growth over the last four years can enter the competition for their chance to be nominated as one of the 50 fastest-growing technology companies in Belgium. Companies that have been active in the technology sector for less than f
/en/news/36_elysia-has-won-deloittes-2019-technology-fast-50-award

Elysia has won Deloitte’s 2019 Technology Fast 50 award
The Technology Fast 50 competition is an annual selection of the 50 fastest growing and innovative technology companies headquartered in Belgium. Public or private companies who develop a technology related product or service and who have experienced substantial revenue growth over the last four years can enter the competition for their chance to be nominated as one of the 50 fastest-growing technology companies in Belgium. Companies that have been active in the technology sector for less than f
/en/news/37_elysia-has-won-deloittes-2019-technology-fast-50-award

Light Medical, our new distributor for UK and Ireland
Light Medical was started by Mark Goodwin and Will Bryan in 2019 after working within the Nuclear Medicine sector for more than 10 years. The goal was to develop a progressive company that provides personalised solutions and builds relationships at every opportunity. Light Medical provides a platform for healthcare professionals to access international manufacturers and products that enables them to develop their service with the best possible tools. We look forward to a fruitful collaboration.
/en/news/83_light-medical-our-new-distributor-for-uk-and-ireland

PET-AlphaSy Project
chemistry or imaging and have secondments at the corresponding partner universities. The fellowships are available from the 1st March 2019 or as soon as possible thereafter. Further information can be found at https://www.alphasy.eu/.If you are interested
/en/news/30_pet-alphasy-project

PET-AlphaSy Project
chemistry or imaging and have secondments at the corresponding partner universities. The fellowships are available from the 1st March 2019 or as soon as possible thereafter. Further information can be found at https://www.alphasy.eu/.If you are interested
/en/news/29_pet-alphasy-project

Elysia-Raytest signs Exclusive Distribution Agreement with EDH for Elysia-Raytest products
collaborating and supporting each other sinceearly 2019, allowing both companies to learn and appreciate each other. It was thislevel of trust that lead both companies to sign the current deal. About EDH Nuclear Medicine and Healthcare Services:EDH is the
/en/news/59_elysia-raytest-signs-exclusive-distribution-agreement-with-edh-for-elysia-raytest-products

Elysia-Raytest signs an Exclusive Distribution Agreement with EDH for Elysia-Raytest products
collaborating and supporting each other sinceearly 2019, allowing both companies to learn and appreciate each other. It was thislevel of trust that lead both companies to sign the current deal. About EDH Nuclear Medicine and Healthcare Services:EDH is the
/en/news/58_elysia-raytest-signs-an-exclusive-distribution-agreement-with-edh-for-elysia-raytest-products

PET Alpha-Sy project - PhD fellows in Organic Chemistry / Radiopharmaceutical Chemistry (more information)
imaging and have secondments at the corresponding partner universities. The fellowships are available from 1 March 2019 or as soon as possible thereafter. More information can be found on https://www.alphasy.eu/. About PET-AlphaSY Our consortium has... February 1st 2019, or before. The terms of employment and salary are in accordance with Belgian regulations and according to the rules and regulations laid down by the European Union’s Horizon 2020 Marie Skłodowska-Curie Action European Training Network
/en/news/33_pet-alpha-sy-project-phd-fellows-in-organic-chemistry-radiopharmaceutical-chemistry-more-information

Contact